. Author manuscript; available in PMC: 2013 Dec 20.

Published in final edited form as: J Urol. 2009 May 17;182(1):10.1016/j.juro.2009.02.105. doi: 10.1016/j.juro.2009.02.105

Table 3.

Response rate, TTP and OS summary statistics

End Point	No. Pts	No. Events	Point Estimate	90%	CI
Response:
Measurable disease	9	5	56%	25	79
50% or Greater PSA decrease	29	22	76%	61	87
90% or Greater PSA decrease	29	9	31%	19	46
TTP:	30	29
Median mos			6.7	4.2	7.7
% 6-Mo rate			57	42	72
% 1-Yr rate			12	2	22
OS rate:	30	20
Median mos			22.0	18.4	25.3
% 1 Yr			90	81	99
% 2 Yr			40	22	57